These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31753019)

  • 1. BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19
    Chen YL; Lin HW; Chien CL; Lai YL; Sun WZ; Chen CA; Cheng WF
    J Immunother Cancer; 2019 Nov; 7(1):313. PubMed ID: 31753019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapeutic effects of B and T lymphocyte attenuator extracellular domain and heat shock protein 70 antigen peptide on cervical cancer in mouse model].
    Han LF; Qiu WM; Hu C; Wang L; Yao HX; Xiong SY; Meng M; Fang Y; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2010 Aug; 45(8):603-8. PubMed ID: 21029617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Lymphocytes in Multiple Sclerosis: Bregs and BTLA/CD272 Expressing-CD19+ Lymphocytes Modulate Disease Severity.
    Piancone F; Saresella M; Marventano I; La Rosa F; Zoppis M; Agostini S; Longhi R; Caputo D; Mendozzi L; Rovaris M; Clerici M
    Sci Rep; 2016 Jul; 6():29699. PubMed ID: 27412504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors.
    Sun WZ; Lin HW; Chen WY; Chien CL; Lai YL; Chen J; Chen YL; Cheng WF
    J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced Innate Inflammation Induced by Anti-BTLA Antibody in Dual Insult Model of Hemorrhagic Shock/Sepsis.
    Cheng T; Bai J; Chung CS; Chen Y; Biron BM; Ayala A
    Shock; 2016 Jan; 45(1):40-9. PubMed ID: 26674453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Xinfeng Capsule increases peripheral blood BTLA expression of CD19(+) and CD24(+) B cells and relieves oxidative stress damage to improve cardiac function of patients with rheumatoid arthritis].
    Sun Y; Liu J; Wan L; Wang F; Qi Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):93-6, 99. PubMed ID: 25575067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B- and T-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity.
    del Rio ML; Kurtz J; Perez-Martinez C; Ghosh A; Perez-Simon JA; Rodriguez-Barbosa JI
    Transplantation; 2011 Nov; 92(10):1085-93. PubMed ID: 21978997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.
    Canaz E; Grabowski JP; Richter R; Braicu EI; Chekerov R; Sehouli J
    Gynecol Oncol; 2019 Sep; 154(3):539-546. PubMed ID: 31230821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative and positive co-signaling with anti-BTLA (PJ196) and CTLA4Ig prolongs islet allograft survival.
    Truong W; Plester JC; Hancock WW; Kaye J; Merani S; Murphy KM; Murphy TL; Anderson CC; Shapiro AM
    Transplantation; 2007 Nov; 84(10):1368-72. PubMed ID: 18049125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LSR Antibody Therapy Inhibits Ovarian Epithelial Tumor Growth by Inhibiting Lipid Uptake.
    Hiramatsu K; Serada S; Enomoto T; Takahashi Y; Nakagawa S; Nojima S; Morimoto A; Matsuzaki S; Yokoyama T; Takahashi T; Fujimoto M; Takemori H; Ueda Y; Yoshino K; Morii E; Kimura T; Naka T
    Cancer Res; 2018 Jan; 78(2):516-527. PubMed ID: 29187404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct expression and inhibitory function of B and T lymphocyte attenuator on human T cells.
    Wang XF; Chen YJ; Wang Q; Ge Y; Dai Q; Yang KF; Fang-Xie ; Zhou YH; Hu YM; Mao YX; Zhang XG
    Tissue Antigens; 2007 Feb; 69(2):145-53. PubMed ID: 17257317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of B and T Lymphocyte Attenuator in Patients with Severe Community-Acquired Pneumonia and the Effect of Steroid Therapy in a Mouse Model.
    Zhou G; Wang D; Liu D; Qi D; Liu Z
    Clin Lab; 2016 Dec; 62(12):2367-2377. PubMed ID: 28164546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are predictive of chemotherapeutic response and prognosis in epithelial ovarian cancer patients treated with platinum-based chemotherapy.
    Miao Y; Yan Q; Li S; Li B; Feng Y
    Cancer Biomark; 2016 Jun; 17(1):33-40. PubMed ID: 27314290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of RIF1 Enhances Sensitivity to Platinum-Based Chemotherapy in Epithelial Ovarian Cancer (EOC) by Regulating Nucleotide Excision Repair (NER) Pathway.
    Liu YB; Mei Y; Tian ZW; Long J; Luo CH; Zhou HH
    Cell Physiol Biochem; 2018; 46(5):1971-1984. PubMed ID: 29719287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unexpected role of B and T lymphocyte attenuator in sustaining cell survival during chronic allostimulation.
    Hurchla MA; Sedy JR; Murphy KM
    J Immunol; 2007 May; 178(10):6073-82. PubMed ID: 17475832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of protein on BTLAlow cells and in vivo antibody-mediated down-modulation of BTLA on lymphoid and myeloid cells of C57BL/6 and BALB/c BTLA allelic variants.
    del Rio ML; Kaye J; Rodriguez-Barbosa JI
    Immunobiology; 2010 Jul; 215(7):570-8. PubMed ID: 19837478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSAID-activated gene 1 mediates pro-inflammatory signaling activation and paclitaxel chemoresistance in type I human epithelial ovarian cancer stem-like cells.
    Kim KH; Park SH; Do KH; Kim J; Choi KU; Moon Y
    Oncotarget; 2016 Nov; 7(44):72148-72166. PubMed ID: 27708225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble B and T lymphocyte attenuator possesses antitumor effects and facilitates heat shock protein 70 vaccine-triggered antitumor immunity against a murine TC-1 cervical cancer model in vivo.
    Han L; Wang W; Fang Y; Feng Z; Liao S; Li W; Li Y; Li C; Maitituoheti M; Dong H; Lai Z; Gao Q; Xi L; Wu M; Wang D; Zhou J; Meng L; Wang S; Ma D
    J Immunol; 2009 Dec; 183(12):7842-50. PubMed ID: 19923459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice.
    Truong W; Hancock WW; Plester JC; Merani S; Rayner DC; Thangavelu G; Murphy KM; Anderson CC; Shapiro AM
    J Leukoc Biol; 2009 Jul; 86(1):41-51. PubMed ID: 19383625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.